Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ptc Therapeutics (PTCT) Non-Current Debt: 2012-2025

Historic Non-Current Debt for Ptc Therapeutics (PTCT) over the last 9 years, with Jun 2025 value amounting to $286.0 million.

  • Ptc Therapeutics' Non-Current Debt rose 0.42% to $286.0 million in Q2 2025 from the same period last year, while for Jun 2025 it was $286.0 million, marking a year-over-year increase of 0.42%. This contributed to the annual value of $285.4 million for FY2024, which is 0.42% up from last year.
  • Latest data reveals that Ptc Therapeutics reported Non-Current Debt of $286.0 million as of Q2 2025, which was up 0.11% from $285.7 million recorded in Q1 2025.
  • In the past 5 years, Ptc Therapeutics' Non-Current Debt registered a high of $573.2 million during Q3 2023, and its lowest value of $281.6 million during Q3 2021.
  • For the 3-year period, Ptc Therapeutics' Non-Current Debt averaged around $371.4 million, with its median value being $285.6 million (2024).
  • As far as peak fluctuations go, Ptc Therapeutics' Non-Current Debt spiked by 102.81% in 2022, and later plummeted by 50.29% in 2023.
  • Over the past 5 years, Ptc Therapeutics' Non-Current Debt (Quarterly) stood at $281.9 million in 2021, then spiked by 102.81% to $571.7 million in 2022, then slumped by 50.29% to $284.2 million in 2023, then rose by 0.42% to $285.4 million in 2024, then climbed by 0.42% to $286.0 million in 2025.
  • Its Non-Current Debt was $286.0 million in Q2 2025, compared to $285.7 million in Q1 2025 and $285.4 million in Q4 2024.